Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion type Assertion NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_head.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion description "[In athymic mice bearing hormone-refractory PC-3 prostate tumor xenografts, intravenous treatment with a liposomal formulation of TNFAIP8 antisense oligonucleotide (LE-AS5) caused reduced expression of TNFAIP8 in tumor tissues, and a combination of LE-AS5 and radiation or docetaxel treatment resulted in significant inhibition of PC-3 tumor growth as compared to single agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_provenance.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion evidence source_evidence_literature NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_provenance.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion SIO_000772 23280553 NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_provenance.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion wasDerivedFrom befree-20140225 NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_provenance.
- NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_assertion wasGeneratedBy ECO_0000203 NP864176.RAymztew6IgaKQoC1i7uL4juMM6p9X6Th_8Zkq1HMncwM130_provenance.